Please login to the form below
Alexa
This page shows the latest Alexa news and features for those working in and with pharma, biotech and healthcare.
Accord Healthcare’s COVID-19 agility praised at PMEA 2020
A huge shout-out to the creative talents of Swordfish Advertising, who pulled our efforts together to effectively showcase this award and, again, thank you to Alexa Forbes Consulting for supporting
Latest news
-
PMEA 2020: continuing to recognise excellence in improving patient outcomes
Taking home this award was Accord’s Agility Ensures Medicines Supply During COVID-19 initiative with support from Alexa Forbes Consulting Ltd. ... Sponsored by: infill healthcare communication. Winner: Accord’s Agility Ensures Medicines Supply During
-
How AI is transforming the way we collect market insights
Leveraging new technologies to gather actionable insights. Amazon’s digital voice assistant Alexa is much more than just a convenient tool for setting reminders, streaming music and controlling the lights in
-
AI: opportunities and barriers to improving healthcare
Despite this, perception is increasingly changing. As wider society embraces new technologies, such as Amazon’s Alexa, there is a noticeable shift in attitude. ... There are a range of concerns, many of which are justified, including the issue of data
-
Four digital health trends set to reinvent and re-energise pharma
Leading analyst Emarketer predicts that over a third of Americans will be using a voice assistant like Siri or Alexa this year, up 9.5% from 2018.
-
Healthcare’s voice revolution
With the UK’s NHS unveiling a major partnership with Amazon’s Alexa, is pharma in danger of being left behind? ... Amazon, for example, is working with developers on a series of software solutions that would enable consumers to ask its virtual
PMEA 2020: continuing to recognise excellence in improving patient outcomes
How AI is transforming the way we collect market insights
AI: opportunities and barriers to improving healthcare
Four digital health trends set to reinvent and re-energise pharma
Healthcare’s voice revolution
More from news
Approximately 0 fully matching, plus 19 partially matching documents found.
Latest Intelligence
-
Trust me, I’m from pharma
For example, progressive organisations are exploring how technology like Amazon Alexa can be used to help the homebound or elderly better manage their health; leveraging the power of the patient voice
-
Pharma’s isolated islands of innovation
Electronic patient health records are becoming the norm. Interaction is moving beyond the computer and phone and into distributed voice-activated services such as Alexa.
-
Speech therapy
AI-powered voice assistants such as Amazon’s Alexa are now a presence in an estimated 30 million homes worldwide, offering an increasingly seamless way for users - particularly those with low ... Indeed, now that Amazon is making its first,
-
How can pharma better engage and empower patients who are socially disadvantaged?
Amazon, for example, is using Alexa’s voice-activated technology for patient self-management of chronic diseases, such as managing diary appointments with doctors and providing medication reminders. ... Indeed, for certain patients, Alexa may play her
-
Can UK pharma rise to the post-Brexit challenge?
Our dominant and thriving industry is one we should be proud of
Trust me, I’m from pharma
Pharma’s isolated islands of innovation
Speech therapy
How can pharma better engage and empower patients who are socially disadvantaged?
Can UK pharma rise to the post-Brexit challenge?
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
Open Road boosts healthcare offering
This is an exciting time for Open Road, as our healthcare practice continues to grow,” said Alexa Knight, head of healthcare at Open Road.
-
JMC Partners appoints veteran healthcare communicator
London-based healthcare communications agency JMC Partners has named Alexa Knight as its new director of policy and projects. ... Alexa has just the skills we require to support us in this exciting phase of JMC's development".
Open Road boosts healthcare offering
JMC Partners appoints veteran healthcare communicator
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Chatbots and voice assistants (VA e.g. Amazon Alexa) are popular examples.
-
4 ways to recruit Alzheimer’s disease patients for your clinical trial
For example, using apps on their phone to engage their memory, or using virtual assistants like Alexa to ask questions in their home.
-
Patients are ready to embrace decentralised clinical trials, are you?
Patients need to be engaged with regularly and in a way that’s convenient for them, which is where telemedicine efforts such as SMS messaging and chatbot type devices like Alexa,
-
Patients are ready for virtual clinical trials, are you?
Patients need to be engaged with regularly and in a way that’s convenient for them, which is where telemedicine efforts such as SMS messaging and chatbot type devices like Alexa,
-
The impact of 5G on digital marketing
Online behaviours, social media interests, conversations with Alexa, health data from wearables, and food choices from your smart fridge will provide a much more accurate picture of our preferences that marketeers ... For communication departments this
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
4 ways to recruit Alzheimer’s disease patients for your clinical trial
Patients are ready to embrace decentralised clinical trials, are you?
Patients are ready for virtual clinical trials, are you?
More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
-
Senior Account Manager
-
Competitive salary offered
-
Omnichannel Strategy Consultant
-
Competitive Salary
- Results of AstraZeneca’s TACKLE phase 3 trial show antibody combination reduces risk of severe COVID-19 or death
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Data shows patients treated with Biogen's MS therapies mount an effective antibody response to COVID-19 vaccination
- US demand for COVID-19 antibody treatments rising fast
- Assessing the value of interim analyses in clinical trials
- AstraZeneca chooses Ireland for $360m manufacturing site
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
- Breaking the silence: It’s time to talk about the menopause
- FDA accepts Regeneron’s REGEN-COV for priority review for treatment of COVID-19
- New data shows Roche's Enspryng significantly reduces neuromyelitis optica spectrum disorder relapses
- Beyond yoga and smoothies – providing real support for employee well-being
- Driving Healthcare Decisions with Natural Language Processing
- Results of AstraZeneca’s TACKLE phase 3 trial show antibody combination reduces risk of severe COVID-19 or death
- Novo Nordisk settles US insulin pricing dispute for $100m
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Onyx Health appoints Dean Forbes
- Sandoz completes acquisition of GSK’s cephalosporin business
- Public is more comfortable with health data sharing if they know it is to support breakthrough treatments and vaccines
PMHub
90TEN
90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...
Latest intelligence
- Breaking the silence: It’s time to talk about the menopause
- Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
- Committing time to making meaningful connections - top 5 tips
- Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
- News:
- Senior Analytics Specialist joins Research Partnership...
